These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
6. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857 [TBL] [Abstract][Full Text] [Related]
7. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease. Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023 [TBL] [Abstract][Full Text] [Related]
9. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511 [TBL] [Abstract][Full Text] [Related]
10. Orthostatic hypotension as a core symptom in a Japanese family harboring SNCA duplication. Nan H; Takaki R; Maruyama T; Baba Y; Ohara S; Shindo K; Takiyama Y Parkinsonism Relat Disord; 2020 Dec; 81():28-30. PubMed ID: 33038703 [No Abstract] [Full Text] [Related]
11. Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra. Corradini BR; Iamashita P; Tampellini E; Farfel JM; Grinberg LT; Moreira-Filho CA Biomed Res Int; 2014; 2014():543673. PubMed ID: 25525598 [TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
14. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mann DM; Yates PO Mech Ageing Dev; 1983 Feb; 21(2):193-203. PubMed ID: 6865505 [TBL] [Abstract][Full Text] [Related]
15. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation. Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations. Proukakis C; Shoaee M; Morris J; Brier T; Kara E; Sheerin UM; Charlesworth G; Tolosa E; Houlden H; Wood NW; Schapira AH Mov Disord; 2014 Jul; 29(8):1060-4. PubMed ID: 24752924 [TBL] [Abstract][Full Text] [Related]
17. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719 [TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia. Del Tredici K; Braak H J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):774-83. PubMed ID: 23064099 [TBL] [Abstract][Full Text] [Related]